COMMUNIQUÉS West-GlobeNewswire

Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

28/12/2017 - 13:00

RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that the company [...]

GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome

28/12/2017 - 13:00

LONDON and CARLSBAD, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

28/12/2017 - 09:05

VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces that Health Canada has issued its research and [...]

The Financial Calendar of AS Olainfarm for 2018

28/12/2017 - 07:50

Olaine, 2017-12-28 07:50 CET (GLOBE NEWSWIRE) -- unaudited financial statements for 2017 on 28 February 2018; unaudited interim financial statement for 3 months of 2018 on May 31, 2018; unaudited interim financial [...]

MDxHealth (R): MDxHealth Announces Lowering of 2017 Guidance

28/12/2017 - 07:01

HERSTAL, BELGIUM and IRVINE, CA - December 28, 2017 - MDxHealth SA (Euronext: MDXH.BR, "MDxHealth", or the "Company"), a world leader in molecular diagnostic prostate cancer testing, today announced that, based on [...]

MDxHealth (R) : MDxHealth annonce une baisse des prévisions

28/12/2017 - 07:01

HERSTAL, BELGIQUE et IRVINE, CA, le 28 décembre 2017 - MDxHealth SA (Euronext : MDXH.BR), un leader mondial dans le diagnostic moléculaire du cancer de la prostate, a annoncé aujourd'hui que, sur base de résultats [...]

The Ensign Group Closes on HUD-Insured Loan Portfolio

27/12/2017 - 22:30

MISSION VIEJO, Calif., Dec. 27, 2017 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]

Digirad Announces Sale of its MDSS Service Contracts to Philips North America

27/12/2017 - 22:05

SUWANEE, Ga., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD ) (the “Company”) today announced that it has entered into a definitive purchase agreement (“the Agreement”) with Philips North America [...]

Acer Therapeutics Announces Partial Exercise of Over-allotment Option in Public Offering

27/12/2017 - 22:01

NEWTON, Mass., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

Emerald Health Therapeutics Awards Stock Options

27/12/2017 - 20:28

VICTORIA, British Columbia, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV:EMH) (OTCQX:EMHTF) has agreed to issue an aggregate of 2,645,000 incentive stock options [...]

Tauriga Sciences, Inc. to Diversify $25,000 of its Balance Sheet Cash into Groestlcoin and Gain Exposure to the Crypto Currency Sector

27/12/2017 - 17:15

NEW YORK, NY, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]

Ossur Hf : Transactions in relation to share buyback program

27/12/2017 - 17:01

Announcement from Össur hf. No. 89/2017 Reykjavík, 27 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

HempAmericana Provides Detailed View Toward an Exciting 2018

27/12/2017 - 16:26

NEW YORK, Dec. 27, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is proud to provide a year-end shareholder update on the Company’s progress toward its key strategic objectives as 2017 winds [...]

Sharecare to Present at J.P. Morgan Healthcare Conference for Fifth Consecutive Year

27/12/2017 - 16:18

ATLANTA, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, today announced it will present at the 36th annual J.P. Morgan Healthcare [...]

Beaucoup de donneurs de sang répondent à l’appel, mais il en faut plus

27/12/2017 - 16:03

OTTAWA, 27 déc. 2017 (GLOBE NEWSWIRE) -- La Société canadienne du sang a observé une augmentation importante des dons de sang depuis le 18 décembre, date à laquelle elle a lancé un appel aux donneurs pour combler les 35 [...]

TOMI Environmental Solutions, Inc. Starts New Year With Inclusion in EPA Lists G, L, and M

27/12/2017 - 15:30

BEVERLY HILLS, Calif., Dec. 27, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]

American Health Council Names Carl Roland, PharmD, MS to Industry Board

27/12/2017 - 15:04

NEW YORK, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Carl Roland, Senior Director at Pfizer, has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise in Clinical [...]

Actinium Pharmaceuticals Provides Update on Pivotal Phase 3 Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial Continue

27/12/2017 - 15:00

Actinium expects enhanced awareness of Iomab-B at ASH annual meeting and expanded site activity to enable completion of trial enrollment by end of 2018, in-line with prior forecast NEW YORK, Dec. 27, 2017 (GLOBE [...]

UPDATE -- Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer

27/12/2017 - 14:56

Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company’s Strategy, Vision and Execution WALTHAM, Mass., Dec. 27, 2017 ( [...]